002919SZSE

Announcement on Completion of Share Repurchase Cancellation and Changes in Share Capital

Mingchen Health Co., Ltd.··4 pages

✨ AI Summary

The company has completed the cancellation of 390,000 repurchased shares, reducing its total share capital from 266,526,066 to 266,136,066 shares. This decision was approved by the board and shareholders, and the cancellation was finalized on May 29, 2026. The repurchased shares were not used for employee stock plans, leading to their cancellation.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Special Reminder:

  1. The number of shares repurchased and canceled by Mingchen Health Products Co., Ltd. (hereinafter referred to as "the Company") is 390,000 shares, accounting for 0.15% of the total share capital (266,526,066 shares) before the cancellation. After the cancellation, the total share capital will decrease to 266,136,066 shares.
  2. The cancellation of the repurchased shares has been completed as confirmed by the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited on May 29, 2026.

According to the Company Law of the People's Republic of China and the Shenzhen Stock Exchange Self-Regulatory Guidelines No. 9 on Share Repurchase, the specific circumstances of the completion of the share repurchase cancellation are announced as follows:

1. Specifics of the Share Repurchase

(1) Share Repurchase Situation

The Company held its seventh meeting of the third board of directors on April 27, 2022, and approved the proposal for the share repurchase plan. The Company intends to use its own funds to repurchase shares through centralized bidding for the purpose of implementing an equity incentive plan or employee stock ownership plan. The type of shares to be repurchased is the ordinary shares (A shares) issued by the Company. The total amount for the share repurchase will not be less than RMB 50 million (inclusive) and not exceed RMB 100 million (inclusive), with a repurchase price not exceeding RMB 35.00 per share (inclusive), and the repurchase period will not exceed 12 months from the date of board approval. For detailed information, please refer to the announcement on the share repurchase plan disclosed by the Company on April 29, 2022, in Securities Daily, Securities Times, China Securities Journal, Shanghai Securities Journal, and the Giant Tide Information Network (www.cninfo.com.cn) (Announcement No.: 2022-015).

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing